Wolters Kluwer appoints Greg Samios as CEO of Health division

Core Viewpoint - Wolters Kluwer has appointed Greg Samios as the new CEO of its Health division, effective June 1, 2025, succeeding Stacey Caywood [1][4]. Group 1: Leadership and Experience - Greg Samios brings over 25 years of experience in the healthcare sector, having previously served as Executive Vice President of the Health division's largest business units, Clinical Effectiveness and Health Learning, Research, and Practice [2]. - Under Samios's leadership, Wolters Kluwer has seen growth in its clinical decision support and drug information products, including UpToDate and Medi-Span, and he has introduced generative AI into the company's healthcare offerings [2][4]. - Samios has a strong educational background, holding an MBA from Duke University and degrees in Engineering from the University of Rochester [3]. Group 2: Company Overview - Wolters Kluwer is a global leader in information solutions, software, and services across various sectors, including healthcare, tax, accounting, legal, and corporate compliance [6]. - The company reported annual revenues of €5.9 billion in 2024 and operates in over 40 countries, employing approximately 21,900 people [7]. - Wolters Kluwer is listed on Euronext Amsterdam and is included in major indices such as AEX and Euro Stoxx 50 [8].